Cargando…
Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7
The positive results of the apatinib phase III trial have cast new light on treatment for patients with advanced gastric cancer (GC). However, in terms of safety, apatinib toxicities may lead to a dose modification or treatment interruption. Therefore, proper intervention is urgently needed to help...
Autores principales: | Ma, Ling, Wang, Zhangding, Xie, Mengyan, Quan, Yunlin, Zhu, Weiyou, Yang, Fengming, Zhao, Chenhui, Fan, Yu, Fang, Na, Jiang, Huning, Wang, Qiang, Wang, Shouyu, Zhou, Jianwei, Chen, Xiaofeng, Shu, Yongqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058073/ https://www.ncbi.nlm.nih.gov/pubmed/32139670 http://dx.doi.org/10.1038/s41419-020-2352-0 |
Ejemplares similares
-
JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells
por: Ma, Ling, et al.
Publicado: (2016) -
Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation
por: Xie, Mengyan, et al.
Publicado: (2020) -
Biocatalysis of ursolic acid by the fungus Gliocladium roseum CGMCC 3.3657 and resulting anti-HCV activity
por: Fu, Shaobin, et al.
Publicado: (2018) -
Turning RacGAP into a RhoGAP
por: Tuma, Rabiya S.
Publicado: (2003) -
Pseudogene RACGAP1P activates RACGAP1/Rho/ERK signalling axis as a competing endogenous RNA to promote hepatocellular carcinoma early recurrence
por: Wang, Meng-Yao, et al.
Publicado: (2019)